Font:
LA

LALPATHLAB / NSE / Healthcare Facilities

Dr. Lal PathLabs

INR 1,539.3-62.20 (-1.20%) 1D
Last updated: 2026-06-16T04:38:17.209472+00:00
Price Chart

1Y Price Trend

Open1,476.7
High1,770
Low1,272.6
Close1,616
Volume2,17,507
Change139.3
Change %9.43%

Key Information

Ticker SymbolLALPATHLAB
Current Price1,539.3
52-Week High1,770
52-Week Low1,272.6
Market Cap25,871.05
Beta0.87
Volume2,17,507
ISININE600L01024
Day High1,628.1
Day Low1,579.2
Open1,625.7

Recommendations

RatingBuy

Target High1,771.3

Target Low1,272

Target Mean1.92

Target Median15

Risk Metrics

Overall RiskBalanced risk

Board Risk31.84

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Dr Lal Pathlabs Ltd is Rated Hold by MarketsMOJO - Markets Mojo16 days ago
Market news

Dr Lal Pathlabs Ltd is Rated Hold by MarketsMOJO Markets Mojo

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo16 days ago
Market news

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo17 days ago
Market news

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo

Dr. Lal PathLabs Schedules Analyst and Institutional Investor Meeting on May 20, 2026 - scanx.trade1 month ago
Market news

Dr. Lal PathLabs Schedules Analyst and Institutional Investor Meeting on May 20, 2026 scanx.trade

Dr. Lal PathLabs FY26 Audited Results: Revenue Up 12.2%, Dubai Subsidiary Approved - scanx.trade1 month ago
Market news

Dr. Lal PathLabs FY26 Audited Results: Revenue Up 12.2%, Dubai Subsidiary Approved scanx.trade

Dr Lal PathLab Standalone March 2026 Net Sales at Rs 675.20 crore, up 16.98% Y-o-Y - Moneycontrol.com1 month ago
Market news

Dr Lal PathLab Standalone March 2026 Net Sales at Rs 675.20 crore, up 16.98% Y-o-Y Moneycontrol.com

Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing - The Economic Times1 month ago
Market news

Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing The Economic Times

Dr Lal PathLabs hits 20% upper band on strong Q4; brokerages stay positive - Business Standard1 month ago
Market news

Dr Lal PathLabs hits 20% upper band on strong Q4; brokerages stay positive Business Standard

FAQ

Stock FAQs

What is the NSE symbol for Dr. Lal PathLabs?

Dr. Lal PathLabs trades on NSE with the symbol LALPATHLAB. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Dr. Lal PathLabs share price and chart?

You can track Dr. Lal PathLabs share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Dr. Lal PathLabs?

Yes. ShareKeyX displays available financial statements for Dr. Lal PathLabs using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Dr. Lal PathLabs?

Yes. ShareKeyX displays available historical OHLC candles for Dr. Lal PathLabs across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Dr. Lal PathLabs belong to?

Dr. Lal PathLabs is classified under Healthcare Facilities in the available company data.

Does ShareKeyX show news for Dr. Lal PathLabs?

Yes. ShareKeyX shows the latest available stock news for Dr. Lal PathLabs from the connected stock news source.